The Compliance Control Ltd, a Northwich, Cheshire, UK-based developer of software that allows biomedical companies to comply with legislation, has received £110k in funding from the North West Fund for Biomedical, managed by SPARK Impact.
The company intends to use the funds, which were provided in conjunction with a Technology Strategy Board award, to continue development and scalability of its solution, as well as to strengthen its sales and marketing activity.
Led by David Forrest, CEO, the Compliance Control provides organizations which are subject to regulatory standards, in sectors such as pharmaceutical, life sciences and medical devices, with software that helps them validate their processes and monitor their compliance in real time.
Using a dashboard traffic light system, ComplianceControl Centre alerts organisations to areas of potential non-compliance, while its cGARD product allows subscribers to access more than 22,500 records of regulations and guidance across various jurisdictions.
FinSMEs
01/10/2012